Abstract

BackgroundPlasmodium falciparum is an obligate intracellular parasite of humans that causes malaria. Falciparum malaria is a major public health threat to human life responsible for high mortality. Currently, the risk of multi-drug resistance of P. falciparum is rapidly increasing. There is a need to address new anti-malarial therapeutics strategies to combat the drug-resistance threat.MethodsThe P. falciparum essential proteins were retrieved from the recently published studies. These proteins were initially scanned against human host and its gut microbiome proteome sets by comparative proteomics analyses. The human host non-homologs essential proteins of P. falciparum were additionally analysed for druggability potential via in silico methods to possibly identify novel therapeutic targets. Finally, the PfAp4AH target was prioritized for pharmacophore modelling based virtual screening and molecular docking analyses to identify potent inhibitors from drug-like compounds databases.ResultsThe analyses identified six P. falciparum essential and human host non-homolog proteins that follow the key druggability features. These druggable targets have not been catalogued so far in the Drugbank repository. These prioritized proteins seem novel and promising drug targets against P. falciparum due to their key protein–protein interactions features in pathogen-specific biological pathways and to hold appropriate drug-like molecule binding pockets. The pharmacophore features based virtual screening of Pharmit resource predicted a lead compound i.e. MolPort-045–917-542 as a promising inhibitor of PfAp4AH among prioritized targets.ConclusionThe prioritized protein targets may worthy to test in malarial drug discovery programme to overcome the anti-malarial resistance issues. The in-vitro and in-vivo studies might be promising for additional validation of these prioritized lists of drug targets against malaria.

Highlights

  • Plasmodium falciparum is an obligate intracellular parasite of humans that causes malaria

  • Plasmodium falciparum alone is responsible for almost all malariainflicted deaths in sub-Saharan Africa, with the continent bearing over 90% of the global P. falciparum burden [3,4,5]

  • The 183 P. falciparum essential proteins identified as human as well as human gut proteome non-homologs were prioritized for downstream analyses

Read more

Summary

Introduction

Plasmodium falciparum is an obligate intracellular parasite of humans that causes malaria. Falciparum malaria is a major public health threat to human life responsible for high mortality. Malaria is a life-threatening infectious disease caused by parasitic protozoan plasmodium. It is a vector borne disease, transmitted to humans through the bite of infected carrier female Anopheles mosquitoes. Among five parasite species that cause malaria in humans, two species, Plasmodium falciparum and Plasmodium vivax, have. Plasmodium falciparum alone is responsible for almost all malariainflicted deaths in sub-Saharan Africa, with the continent bearing over 90% of the global P. falciparum burden [3,4,5]. More than 85% of confirmed recorded cases and deaths in Asia occurred in India, Indonesia, Myanmar, and Pakistan [7]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call